REQUEST A DEMO
Total
USD $0.00
Search more companies

Upkar Remedies Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Upkar Remedies Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Upkar Remedies Private Limited is a company in India, with a head office in Chennai. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on January 28, 1994. The latest financial highlights indicate a net sales revenue increase of 19.24% in 2025. Its total assets grew by 35.4% over the same period. The enterprise’s net profit margin increased by 19.95% in 2025.

Legal Address
Old No.02, New No.3 Barnaby Road, Kilpauk
Chennai; Tamil Nadu; Postal Code: 600010

Contact Details: Purchase the Upkar Remedies Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Upkar Remedies Private Limited report to view the information.
Financial Auditors:
Purchase the Upkar Remedies Private Limited report to view the information.
Incorporation Date:
January 28, 1994
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
89.8%
Purchase this report to view the information.
10.2%
Company Performance
Financial values in the chart are available after Upkar Remedies Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
19.24%
Total Operating Revenue
28.53%
Operating Profit
44.63%
EBITDA
44.46%
Net Profit/Loss for the Period
50.28%
Total Assets
35.4%
Total Equity
45.95%
Operating Profit Margin
22.94%
Net Profit Margin
19.95%
Return on Equity (ROE)
0.9%
Debt / Equity
-4.07%
Quick Ratio
-0.05%
Cash Ratio
-0.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?